Baseline characteristics of participants with plantar fasciitis allocated to ultrasound guided dexamethasone or placebo. Values are means (SDs) unless otherwise stated
| Variable | Dexamethasone group (n=41) | Placebo group (n=41) |
|---|---|---|
| Age in years | 51.7 (11.9) | 53.6 (9.0) |
| No (%) of women | 22 (53.7) | 17 (41.5) |
| Body mass index | 31.4 (5.5) | 30.9 (5.4) |
| Median (interquartile range) duration of symptoms in months | 9.0 (8.0) | 12.0 (11.5) |
| No (%) of bilateral cases | 12 (29.3) | 12 (29.3) |
| Foot health status questionnaire: | ||
| Pain score at baseline | 36.8 (19.9) | 35.8 (20.4) |
| Function score at baseline | 53.4 (25.5) | 60.2 (25.3) |
| Plantar fascia thickness in mm at baseline | 6.67 (1.53) | 6.29 (1.20) |
| First step pain in mm at baseline | 62.2 (20.6) | 60.5 (22.7) |